A new study offers an innovative way to track the spread of leishmaniasis, a parasitic disease affecting both animals and humans.
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 21/12/2024 03:20
A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that afflicts about 1 million people and kills about 30,000 people around the world every year.
A new study offers an innovative way to track the spread of leishmaniasis, a parasitic disease affecting both animals and humans.
A new study offers an innovative way to track the spread of leishmaniasis, a parasitic disease affecting both animals and humans.
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk. ......
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk. ......
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk.
BAVINA SOOKDEO According to the International Diabetes Federation, presently, the prevalence of diabetes is between 12 to 15 per cent of our...
BAVINA SOOKDEO According to the International Diabetes Federation, presently, the prevalence of diabetes is between 12 to 15 per cent of our...
New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad cholesterol and triglycerides in...
New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad cholesterol and triglycerides in...
(Stock photo Dreamstime) In a cutting-edge medical experiment, a small group of people who had high cholesterol despite taking conventional drugs to...